Thomas Simon, DPM
Podiatrist · Holladay, UTNPI 1356832398
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Medical Device Business Services, Inc. at 30.2% of the total. Reporting peaked in 2020 at $1,327 and has fallen 90.7% since, to $123 in 2025.
Across 45 payments — averaging $62.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$855
- Pylant Medical$581
- Stryker$527
- Bone Support Inc.$384
- Johnson & Johnson$117
- Medtronic$111
- plus $253 from 12 others
What the payments were for
- Food & beverage$1,39249%
- Education$1,43651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $855 |
| Pylant Medical | 1 | $581 |
| Stryker | 15 | $527 |
| Bone Support Inc. | 3 | $384 |
| Johnson & Johnson | 4 | $117 |
| Medtronic | 3 | $111 |
| Treace Medical Concepts, Inc. | 3 | $48 |
| Boston Scientific | 2 | $40 |
| Biocomposites Inc | 1 | $27 |
| Smith+Nephew | 1 | $21 |
| Surgenex LLC | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $14 |
| Mimedx Group, Inc. | 1 | $13 |
| Anika Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERAMENTBONE VOID FILLER$293
- T2$122
How this compares
$2,828 in reported general payments places this provider in the 70th percentile of 59 podiatrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 19 | $218 |
| Doxycycline Hyclate | 14 | $145 |
| Methylprednisolone | 14 | $134 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $74 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $63 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Holladay
- Jason BruseLayton$203K
- Anna HronekSalt Lake City$82K
- Michele CarrDraper$56K
- David GraffOgden$39K
- Clark LarsenMurray$16K
- Kelly HamblinWest Jordan$13K
- Mikol AndersonSalt Lake City$9K
- Thomas EddyMurray$7K
- Andrew EvansSt George$6K
- Jason LucasOgden$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.